Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Overweight or Obesity

Overweight or Obesity

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Overweight or Obesity

7 trials tracked for Overweight or Obesity: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 4400 citations.

7Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 2 Other / NA 4
  1. Phase 3 STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity Completed · 4,400 cited
  2. Phase 2 Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese Completed
  3. Phase 2 Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study Completed
  4. N/A A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program Completed
  5. N/A A 6-month Observational Study on Combined Oral Contraceptives and Body Weight in Pre-Menopausal Women With Overweight or Obesity Completed
  6. N/A eMOTION Formative Study Completed
Show 1 more trials
  1. N/A Indigenous Supported Agriculture "Go Healthy" Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Semaglutide improves physical quality of life in schizophrenia with prediabetes
Psychiatry RCT
Semaglutide improves physical quality of life in schizophrenia with prediabetes Semaglutide improves physical quality of life in adults with schizophrenia and obesity
This secondary analysis of a randomized trial in 154 adults with schizophrenia, prediabetes, and overweight or obesity found that once-weekl…
A secondary analysis of a trial found that once-weekly semaglutide improved physical quality of life in adults with schizophrenia and obesit…
May 1, 2026
Monitoring report on US GLP-1 RA prescribing trends shows increased oral semaglutide use
Diabetes & Endocrinology
Monitoring report on US GLP-1 RA prescribing trends shows increased oral semaglutide use Why are so many people getting new diabetes and weight-loss drugs?
This monitoring report analyzes real-world US electronic health record data from Truveta on GLP-1 RA prescribing.
Prescriptions for diabetes and weight-loss drugs jumped sharply in the US after a new oral pill was approved, with first-time use rising ove…
medRxiv Apr 19, 2026